Quarterly Newsletter – Q3 2022
We have been immensely pleased with the strong showing of the Biotech Social Pact (BSP) throughout our markets this year. In this second iteration of our quarterly newsletter, you will find below an overview of recent BSP achievements and news coverage, of upcoming activities, and our current calls to action and opportunities for you to participate actively in BSP activities.
The French BSP Local Chapter received a reaction from the Élysée on its call for a Secretary of State for Biotech. In the UK, the Pharma Letter published an Op-ed by Amicus CEO John F. Crowley and Amicus General Manager for the UK and Ireland Charlie Galvin on the BSP. On 19th September, the Portuguese BSP Local Chapter was officially launched during BioMeet22. In terms of upcoming activities, we want to highlight our International Biotech Conference that we are organizingin partnership with Project Syndicate and for which exciting sponsorship opportunities are available. More details of all of this can be found below.
Before going into detail, we would like to bring special attention to and warmly welcome our new signatories:
| Rui Amandi de Sousa, CEO at Stemmatters | Raquel Fortunato, CEO at GenIbet |
| Filipe Assoreira, Co-Founder and ex-CEO at Nano4 Global | David Braga Malta, Venture Partner at Pictet Private Equity |
| Paulo Barradas, CEO at Bluepharma | Sébastien Iva, CEO at Fab’entech |
| Richard Francis, CEO atPureSpring Therapeutics | José Pereira-Leal, Founder and CEO at Ophiomics |
| Pedro Castanheira, Head of Protein Sciences at Immunethep | Giacomo Chiesi, Head of Global Rare Diseases at the Chiesi Group |
| António Portela, CEO at BIAL | Henrique Veiga Fernandes, Founder and CSO at LiMM Therapeutics |
| Daniela Couto, Partner at BioGeneration Ventures | Sérgio Simões, CEO at Luzitin |
| David Cristina, Executive Director at Fosun | Simão Soares, Co-Founder and CEO at SilicoLife |
| Rosamond Deegan, CEO atOMass Therapeutics | Bruno Santos, Co-Founder and CEO at Immunethep |
We are honored and delighted that they have joined the Biotech Social Pact and we are looking forward to our cooperation. With the new signatories, the BSP has also hit the 100 signatories mark! In total, the BSP now has 103 signatories.
Recent Activities – France
Earlier this year, several BSP signatories and members of the French BSP Local Chapter have called for the creation of a new position of Secretary of State for Biotech in the new French government.
The Office of French Prime minister Elisabeth Borne has sent a response on 19 July underlining the importance of the biotech sector for France. It’s not often a Prime minister reacts to messages such as these, so we consider this to be a fantastic sign that the importance of biotech, and the work of the BSP, is recognized by the French government.
Recent Activities – UK
On 28th July, the Pharma Letter, a leading British biotech and pharmaceuticals news service, published an Op-ed of Amicus CEO John F. Crowley and Amicus General Manager for the UK and Ireland Charlie Galvin on the value of the BSP for sustainable access to life-changing treatments for patients and healthcare systems across the UK.
This OpEd was based on a fantastic speech given by Charlie to the British Royal Pharmaceutical Society, during which the need for the BSP and it’s mission was conveyed to a room filled with high-level stakeholders in British pharmaceuticals and public bodies.
Read the full Op-ed here.
Recent Activities – Portugal
On 19th September, BioMeet22 took place in Oeiras, Portugal, where the Portuguese Chapter of the BSP was officially launched.
The Pact was signed by no less than 14 Portuguese biotech leaders in the company of an esteemed audience, which included Portuguese Minister for Economy and Maritime Affairs Antonio Costa Silva, who congratulated and welcomed the signature of the BSP in Portugal in his closing remarks.
We are overjoyed that the BSP and its mission continues to grow across Europe!
The BSP received high visibility at the event in the form of posters, banners and leave-behinds shared with attendes. The event was also attended by journalists, and we are pleased to have already achieved two media publications at SAPO and Expresso. The event was live streamed and a recording is available here. Furthermore, the Op-ed from Steering Committee members Julien Patris (Alnylam) and Anant Murthy (argenx) has been published on 2 October in Observador and can be read in full here.
We are immensely grateful to P-BIO and Expresso for their support and collaboration in preparation for this milestone event.
Looking Forward…
Later this year (exact date TBC), the BSP will be organising an International Biotech Conference called The Next Health Revolution, in partnership with Project Syndicate.
The conference will take place in Paris and aims to boost awareness and enthusiasm for strengthening the biotech ecosystem in Europe as well as make the BSP better known among leading policymakers.
We are excited to share with all signatories that sponsorship opportunities for the conference are still available. These sponsorships are a great opportunity to raise corporate visibility of your brand on all conference materials, and for engagement with the speakers at the conference. Full sponsorship benefits are as follows:
| PREMIUM | SUPPORTER | ATTENDEE |
| Senior Executive participation in thematic Biotech Social Pact film, to be broadcast during event All benefits from previous levels | Logo placement on event materials on location in Paris Secondary logo placement on event website All benefits from previous level | Two tickets to the in-person event in Paris Access to the post-event networking session with refreshments |
| €5,000 | €2,000 | €1,000 |
Current signatory sponsors include Agomab Therapeutics, Alnylam Pharmaceuticals, Amicus Therapeutics, argenx, Ovid Therapeutics and Sensorion.
Should you be interested in discussing these sponsorship opportunities further, please do not hesitate to contact us via [email protected]. We are also happy to arrange a call with Project Syndicate to further present and discuss the project.
If you want to participate more actively in BSP activities, either by joining Steering Committee or by joining a local chapter, or if want to notify a change of position, if you want to be removed from this distribution list of from the list of signatories, please get in touch with the Secretariat at [email protected].
